Somerset, NJ – Nov. 6, 2015 – LabVantage Solutions and Cambridge Biomedical announce the implementation of LabVantage laboratory information management system (LIMS).
After an extensive investigation of LIMS systems suitable for both clinical diagnostic and clinical research aspects of their business, Cambridge Biomedical has entered into an agreement to implement LabVantage with a targeted launch in spring 2016.
“This marks a milestone on our continuing commitment to providing our clients best-in-class service and our continual commitment to quality” said Anthony Davis, Director of Quality Assurance “I am proud to be the project leader on this endeavor and excited by the tremendous opportunities this will bring to our organization.”
Peter Bailey, LabVantage CEO stated, “We are excited to begin our partnership with Cambridge Biomedical, a world class leader in bioanalytical services. Our goal at LabVantage is to help companies such as Cambridge Biomedical use technology to run their laboratories more efficiently. We know our LIMS solution will enable Cambridge Biomedical to continue their advances in scientific research.”
LabVantage, a configurable, web-based LIMS, is trusted by industry leaders worldwide to run their laboratories and operate with the highest level of efficiency, effectiveness and quality. Whether it’s in the preclinical, clinical, and post market stages of drug or device development LabVantage’s solutions offer a level of security organizations such as Cambridge Biomedical need to better support their clients.
About Cambridge Biomedical
Cambridge Biomedical, based in Boston, Massachusetts, supports sponsors by developing customized assays for small and large molecules, biomarkers, and other critical analytes, along with validation and sample testing in our CLIA certified and CAP accredited, GLP/GCLP compliant facilities, The Company has extensive expertise in technology transfer, assay development, optimization and validation. It also offers specific services in analytical support for PK/PD studies, biomarker development, clinical assay development, assay validation, specimen analysis, and testing services in support of clinical trial and drug or device development. Our personalized project methodology, along with a focus on delivering quality results and regulatory submission ready documentation and rapid turnaround times, ensures we meet our client’s product development timelines.
